Summary & Overview
CPT 78278: Abdominal and Pelvic Radionuclide Bleeding Scan
CPT code 78278 represents a nuclear medicine abdominal and pelvic bleeding scan performed after administration of a radiopharmaceutical to localize gastrointestinal hemorrhage when active bleeding is not directly visualized or when bleeding obscures bowel visualization. This study matters nationally as a diagnostic tool in acute and occult GI bleeding cases where accurate localization can guide further intervention and affect downstream resource use.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and the service type. The publication outlines what stakeholders can expect to learn about utilization benchmarks, coding and billing considerations, and policy or coverage trends relevant to radionuclide bleeding scans. It also highlights common modifiers and coding relationships where available. Data not available in the input is noted explicitly where applicable.
Billing Code Overview
CPT code 78278 describes a nuclear medicine imaging study in which the provider images a wide area including the lower portion of the liver and spleen and the entire abdomen and pelvic region after administration of a radiopharmaceutical or tracer. The procedure is performed to identify the site of gastrointestinal bleeding when there is no direct evidence of active bleeding in the lower gastrointestinal tract or when active bleeding interferes with adequate visualization of the bowel.
-
Service type: Nuclear medicine bleeding scan (radionuclide imaging) to localize gastrointestinal hemorrhage
-
Typical site of service: Hospital imaging department or outpatient nuclear medicine center, often performed in settings equipped for radiopharmaceutical administration and abdominal/pelvic imaging
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient presents to the emergency department with signs of acute gastrointestinal hemorrhage: progressive orthostatic hypotension, a drop in hemoglobin, and melena without clear source on nasogastric lavage or colonoscopy. The clinical team administers a radiopharmaceutical tracer and obtains a wide-field abdominal and pelvic scintigraphic study to localize active or intermittent bleeding when direct endoscopic visualization is nondiagnostic or not feasible. Typical workflow: triage and stabilization in ED, intravenous access and labs including type and crossmatch, consultation with nuclear medicine or interventional radiology, informed consent for radionuclide bleeding scan, administration of tracer (usually labeled red blood cells or technetium-labeled agents), dynamic and delayed imaging of the lower liver/spleen through pelvis to identify extravasation, image interpretation by a board-certified radiologist or nuclear medicine physician, and communication of localization to the gastroenterology or interventional radiology team for potential angiography or surgical planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation/read of the scintigraphic study separate from technical imaging services. |
TC |